Cost-effectiveness of Infloran (TM) in Treating Acute Childhood Diarrhea in Phramongkutklao Hospital

Phramongkutklao College of Medicine and Hospital128 enrolled

Overview

The purpose of this study is to determine whether the probiotic Infloran is cost-effective in treating acute childhood diarrhea.

Probiotics have been proved to shorten duration of diarrhea in children; whether they are cost-effective is less clear. We'd like to validate the use of Infloran, a proprietary probiotic sold in Thailand, in terms of its cost-effectiveness compared to standard diarrhea care in our hospital setting.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

QUADRUPLE

Enrollment

128

Conditions

Acute Diarrhea

Interventions

Probiotic - InfloranDRUG

Drug:Probiotic - Infloran (TM) 1 cap (1 billion CFU of L. acidophilus and 1 billion CFU of B. bifidum) PO bid or tid

Eligibility

Sex: ALLMin age: 3 MonthsMax age: 6 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children 3 months to 6 years of age * Hospitalized due to acute diarrhea Exclusion Criteria: * History of probiotic treatment in this episode of illness * History of use of other anti-diarrheal medications * Chronic gastrointestinal disease(s) * Severe dehydration * Severe systemic disease(s)

Locations (1)

Department of Pediatrics, Phramongkutklao Hospital

Bangkok, Thailand

RECRUITING

Outcomes

Primary Outcomes

monetary cost of hospitalization in Thai Baht

Time frame: from admission to discharge date, approximately 1-7 days

Secondary Outcomes

days of hospitalization

Time frame: from admission to discharge date, approximately 1-7 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.